Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes.
Front Pharmacol. 2022 Jul 19;13:881385. doi: 10.3389/fphar.2022.881385. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35928283
Free PMC article.
Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome.
Stensen W, Rothweiler U, Engh RA, Stasko MR, Bederman I, Costa ACS, Fugelli A, Svendsen JSM.
Stensen W, et al. Among authors: fugelli a.
Pharmaceuticals (Basel). 2021 Nov 17;14(11):1170. doi: 10.3390/ph14111170.
Pharmaceuticals (Basel). 2021.
PMID: 34832952
Free PMC article.
Item in Clipboard
LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus.
Nilsson AC, Janson H, Wold H, Fugelli A, Andersson K, Håkangård C, Olsson P, Olsen WM.
Nilsson AC, et al. Among authors: fugelli a.
Antimicrob Agents Chemother. 2015 Jan;59(1):145-51. doi: 10.1128/AAC.03513-14. Epub 2014 Oct 20.
Antimicrob Agents Chemother. 2015.
PMID: 25331699
Free PMC article.
Clinical Trial.
Item in Clipboard
In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.
Saravolatz LD, Pawlak J, Johnson L, Bonilla H, Saravolatz LD 2nd, Fakih MG, Fugelli A, Olsen WM.
Saravolatz LD, et al. Among authors: fugelli a.
Antimicrob Agents Chemother. 2012 Aug;56(8):4478-82. doi: 10.1128/AAC.00194-12. Epub 2012 May 14.
Antimicrob Agents Chemother. 2012.
PMID: 22585222
Free PMC article.
Item in Clipboard
Eletriptan Pfizer.
Strijbos PJ, Parsons AA, Fugelli A.
Strijbos PJ, et al. Among authors: fugelli a.
Curr Opin Investig Drugs. 2002 Sep;3(9):1359-68.
Curr Opin Investig Drugs. 2002.
PMID: 12498013
Review.
Item in Clipboard
Autoradiographic localization of 5-HT1E and 5-HT1F binding sites in rat brain: effect of serotonergic lesioning.
Fugelli A, Moret C, Fillion G.
Fugelli A, et al.
J Recept Signal Transduct Res. 1997 Jul;17(4):631-45. doi: 10.3109/10799899709039154.
J Recept Signal Transduct Res. 1997.
PMID: 9220372
Item in Clipboard
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G.
Massot O, et al. Among authors: fugelli a.
Mol Pharmacol. 1996 Oct;50(4):752-62.
Mol Pharmacol. 1996.
PMID: 8863819
Item in Clipboard
Mechanisms of long-term dark adaptation.
Stabell U, Stabell B, Fugelli A.
Stabell U, et al. Among authors: fugelli a.
Scand J Psychol. 1992;33(1):12-9. doi: 10.1111/j.1467-9450.1992.tb00808.x.
Scand J Psychol. 1992.
PMID: 1594893
Review.
Item in Clipboard
Cite
Cite